A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

NCT07213817 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Solid Tumor
Metastatic Solid Tumor

Interventions

BIOLOGICAL: IPN60300

Sponsor

Ipsen